Año 2023 / Volumen 115 / Número 8
Original
Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review

418-427

DOI: 10.17235/reed.2022.8796/2022

David Avelar-Rodríguez, Rubén Peña-Vélez, Jelena Popov, Lee Hill, Paul MacDaragh Ryan,

Resumen
Background: non-alcoholic fatty liver disease (NAFLD) in childhood is an increasing global public health issue with significant long-term consequences. NAFLD management mainly consists of lifestyle modifications, however, adjunct pharmacological therapies are currently lacking. Gut microbiota manipulation via probiotics may alter the course of pediatric NAFLD. The objective of this systematic review was to synthesize all the available literature on the use of probiotics in children and adolescents with NAFLD. Methods: PubMed, EBSCOhost, Scopus, Web of Science, and Cochrane Library were systematically searched for trials on the use of probiotics in pediatric NAFLD. A quantitative DerSimonian Laird random effects meta-analysis was performed when possible; otherwise, a narrative summary of the study outcomes was presented and discussed. A separate search was completed to include all the ongoing registered trials on probiotics use in pediatric NAFLD. Results: five randomized controlled trials met the inclusion criteria. Of these, four trials were included in the final quantitative analysis. Probiotic therapy significantly reduced the levels of alanine aminotransferase (ALT) (mean difference: -10.39 [-19.85, -0.93]), however significant heterogeneity between studies was identified (I2, 93 %). Conclusions: there is insufficient evidence to support probiotics in the treatment of pediatric NAFLD given the substantial degree of discordance amongst the available trials. Lifestyle modifications focusing on maintaining a normal BMI and regular exercise continue to be the gold standard approach to treating NAFLD in children.
Resumen coloquial
Non-Alcoholic Fatty Liver Disease in childhood is an increasing public health issue globally with significant long-term consequences. Non-Alcoholic Fatty Liver Disease management mainly consists of lifestyle modifications, however, adjunct pharmacological therapies are currently lacking. Gut microbiota manipulation via probiotics may alter the course of pediatric Non-Alcoholic Fatty Liver Disease. 5 randomized controlled trials met the inclusion criteria. Of these, 4 trials were included in the final quantitative analysis. Probiotic therapy significantly reduced the levels of alanine amino transferase (mean difference, -10.39 [-19.85, -0.93]), however significant heterogeneity between studies was identified (I2, 93%). There is insufficient evidence to support probiotics in the treatment of pediatric Non-Alcoholic Fatty Liver Disease given the substantial degree of discordance amongst the available trials. Lifestyle modifications focusing on maintaining a normal body mass index and regular exercise continue to be the gold standard approach to treating Non-Alcoholic Fatty Liver Disease in children.
Share Button
Nuevo comentario
Comentarios

09/08/2023 5:18:07
Donde encuentro el artículo en PDF en español?


Artículos relacionados
Instrucciones para citar
Avelar-Rodríguez D, Peña-Vélez R, Popov J, Hill L, Ryan P. Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review. 8796/2022


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 1635 veces.
Este artículo ha sido descargado 145 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 17/03/2022

Aceptado: 08/11/2022

Prepublicado: 22/11/2022

Publicado: 26/07/2023

Tiempo de revisión del artículo: 165 días

Tiempo de prepublicación: 250 días

Tiempo de edición del artículo: 496 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas